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Summary.-Experiments were conducted to determine whether the histological
pattern of tumour growth of hormone-responsive MCF-7 human mammary adeno-
carcinoma varied in different tissues of athymic mice. Tumours in the uterus follow-
ing intrauterine injection were rapidly proliferating and highly invasive. Tumours
injected intracerebrally were also highly invasive. In contrast, s.c. tumours and those
which arose in the lung following intrapleural injection, grew as small localized
nodules without evidence of aggressive invasion of surrounding tissues. These
findings indicate that selective implantation of human tumours in athymic mice
can be used to develop different models of tumour growth and aggressiveness.
THERE HAS BEEN a continuing effort to
develop new models of clinical neoplasia
using human tumours xenografted into
athymic mice. Historically, almost all
these attempts have involved the sub-
cutaneum as the site of tumour implanta-
tion. Often these s.c. tumours produce
only small, slow-growing non-invasive
lesions. Clinically such tumours are rarely
life-threatening and are generally manage-
able by surgical and/or radiological inter-
vention. Although, experimentally, s.c.
tumours with this slow, non-aggressive
pattern of growth may be of interest in
studies of tumour nidation, vasculariza-
tion or other early tumour behaviour,
they do not mimic the life-threatening
aspect of visceral metastatic disease.
Visceral metastatic tumours may produce
large invasive tumour burdens that kill
the host. It is this aggressive form of the
disease which is the subject of most trials
of new therapies (Phase II trials). There-
fore new xenograft models should be
developed which reflect advanced disease.
One method of developing xenograft
models of visceral metastatic disease is to
implant the human tissue atsitesthat more
closely reflect their tissue of origin, or
sites at which a particular tumour type is
predicted to metastasize. Compared to
simple s.c. implantation, manipulations of
this type might be expected to reflect more
closely the biological potential of human
tumours. In this paper we report on the
divergent growth characteristics of the
human hormone-responsive MCF-7 mam-
mary-tumour cell line in different tissues
ofthe athmyic mouse. The MCF-7 cell line
was established from a pleural effusion in
a patient diagnosed with a primary mam-
mary carcinoma (Soule et al., 1973) and
contains oestrogen receptors (Brooks et al.,
1973). The conditions under which the
MCF-7 cell line will grow in athymic mice
have recently been partly elucidated. In
normal female athymic mice without
hormone supplementation MCF-7 cells
injected s.c. do not grow progressively.
However, when MCF-7 cells are implanted
s.c. in athymic mice receiving ectopic
oestradiol (Soule & McGrath, 1980) or
pituitary transplants (Russo et al., 1977;
Ozzello & Sordat, 1980) progressive tum-
our growth ensues. Given this difference
in growth patterns, and observations that
these cells contain receptors for the major
steroid sex hormones (Brooks et al., 1973;J. A. LEVY, A. C. WHITE AND C. M. McGRATH
Horwitz et al., 1975; Lippman et al., 1976),
this tumour is considered hormone-
dependent. As such we have been inter-
ested in developing a model from these
cells for studying advanced visceral human
disease and the effects of the host's
microenvironment on the growth pattern
ofthe tumour.
MATERIALS AND METHODS
Cell culture.-MCF-7 cells were maintained
in Hanks' Minimal Essential Medium (Flow
labs) supplemented with 10% bovine calf
serum (K-C Biochemicals), 12-5 ,tg/ml insulin
(Sigma Chemical) and penicillin-streptomy-
cin (Flow Labs). Cells for injection were
harvested by scraping, washed twice and
resuspended in phosphate-buffered saline at
5 x 106 cells per 0 05 ml.
Mice.-Female athymic (nu/nu) BALB/c
mice (18-22 g) were obtained from Life
Sciences Corpn., St. Petersburg, Florida and
maintained in laminar-flow cage racks. Cages,
food and water were heat-sterilized.
Injection of tumour cells.-For intrauterine
injection ofMCF-7 cells, mice were anaesthet-
ized with pentobarbital. The right uterine
horn was exposed and 0-02 ml of tumour-
cell suspension was injected cephalically into
the uterine lumen - 5 mm below the ovaries.
For intrapleural injection mice were anaes-
thetized with pentobarbital and 0 05 ml of
tumour-cell suspension was injected into the
pleural cavity using a 26-gauge, 3/8" needle.
Intracerebral injections of0-02 ml oftumour-
cell suspension were placed 2 mm left of the
midline and 1 mm in front of the ear axis.
For s.c. injection, mice received 0 05 ml of
the tumour suspension in the left ventro-
caudal quadrant.
Hormone supplementation.-Silastic im-
plants 1 cm in length containing 4-6 mg
oestradiol-17/ (Sigma Chemical) were pre-
pared as described by Legan et al. (1975).
At the time of tumour inoculation, hormone
implants were inserted s.c. through a small
dorsal incision which was closed with sterile
wound clips.
Oestradiol content of tissues. Mice were
injected i.p. with 20 juCi [2,4,6,7-3H(N)]-
oestradiol (101-7 Ci/mmol, New England
Nuclear) and killed by exsanguination 60 min
later. Tissue specimens of lung, uterus, peri-
ovarian fat with oviducts, whole brain,
subcutaneum and liver were excised, washed
in cold saline and frozen. To determine the
ability of these organs to take up hormone
and retain non-metabolized oestradiol the
samples were homogenized, ether-extracted
and chromatographed. Immediately after
homogenization, aliquots of each tissue were
solubilized in aquasol (New England Nuclear)
and the amount of oestradiol taken up deter-
mined by liquid-scintillation counting. Non-
metabolized oestradiol remaining in the
tissue was determined by paper chromato-
graphy. Ether extracts of the homogenized
tissues were evaporated and redissolved in
100 pl methanol. Samples were spotted on
SA sheets (Gelman) and chromatographed in
97:3 chloroform-methanol, along with a
purified oestradiol standard. Chromatographs
were visualized with the aid ofiodine vapour.
Spots co-migrating with the oestradiol stand-
ard were cut out, iodine allowed to revaporize,
then eluted into 1 ml ethanol. Samples were
then mixed with a toluene-PPO-POPOP
fluor, and radioactive oestradiol determined.
The protein content of the specimens were
determined using Coomassie Blue dye (Bio-
rad) as described by Bradford (1976).
RESULTS
In order to determine the growth char-
acteristics of MCF-7 tumours in diverse
murine host tissues, tumour cells were
injected into the brain, uterus, pleural
cavity or subcutaneum of athymic mice.
Three weeks later the mice were killed and
the extent oftumour mass was determined
grossly and histologically (Table I). We
observed that as early as 21 days after
intrauterine injection of MCF-7 cells,
TABLE I.-Host-site influence on MCF-7
tumour grwothpattern
Site of Hormone Tumour Invasive-
implant supplement size ness
Uterus Oestradiol 350-1300 mg +
Placebo 70-900 mg +
Brain Oestradiol not done +
Lung Oestradiol 2-4 mm2
Subcutaneum Oestradiol 5+ 60 mg
Groups of 6 athymic female mice were inoculated
with MCF-7 tumour cells at the sites indicated.
At 3 weeks the mice were killed, the tumours
removed, weighed and prepared for histology.
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100% (6/6) and 37% (3/8) of mice that
receive oestrogen or placebo implants
respectively developed large tumours. In
these experiments uterine tumour weights
were corrected for oestradiol-induced
hypertrophy or basal uterine weights.
Control females implanted with placebo
silastic had uterine weights of 28 + 18 mg.
Three weeks after insertion of oestradiol
implants, control mice had serum oestro-
gen levels > 1 ng/ml and uterine wet
weights of 140 + 55 mg. Average tumour
masses, when corrected for the appropriate
uterine weight, were 800 + 172 mg and
650 + 220 mg for oestradiol and placebo
treatments respectively. Tumours in both
oestradiol-supplemented and placebo-
implanted mice were highly invasive and
periuterine, involving the uterus, ovary,
oviducts and periovarian fat. On histo-
logical evaluation, uterine invasion exhibi-
ted 3 distinct patterns: en bloc, in clusters
and as finger-like projections (Indian-file)
into uterine tissue. The cluster form of
uterine invasion is shown in Fig. 1 and the
Indian-file form in Fig. 2. The most
agressive periuterine tumours also invaded
adjacent peritoneal muscle (Fig. 3) but
neither kidney or hepatic invasion was
noted.
The growth pattern of MCF-7 cells
injected into the brains of oestradiol-
supplemented athymic mice was similar
to that found in uteri and its neighbouring
fat. Although gross tumour was not visible
at necropsy, widespread tumours were
found in histological sections from all the
mice (6/6). In all cases tumour growth was
11
FIG. 1. MCF-7 cells (arrows) invading the uterus in cluster form (H. & E. x 100).
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FIG. 2. MCF-7 cells (arrows) invading the uterus in Indian-file forrn (H. &; E. x 100).
evident throughout the ventricular spaces,
and diffusely invasive into the cerebrum
(Fig. 4). The intracerebral tumours we
observed had poorly defined limits, and
appeared to project indiscriminately into
cortical white matter.
The intracerebral growth of MCF-7
tumours was not directly related to the
brain's position as an immunoprivileged
site, since 8 weeks after MCF-7 inoculation
no cells were detected in the brains of
either 20 male or 20 female nu/nu hetero-
zygous mice. Likewise, no malignancy was
detected in 6 male homozygous nude
mice, indicating thatreven in the cerebral
site MCF-7 tumourigenesis is hormone-
dependent.
In contrast to the aggressive growth
patterns in the brain and uterus, s.c.
MCF-7 tumours grew slowly (Table I)
and no invasion beyond the subcutaneous
tissue was seen (Fig. 5). At 3 weeks after
tumour-cell implant tumour weights
rangedfrom 5 to 60 mg. Similarly, only 1/6
mice receiving intrapleural tumour-cell
injections exhibited a tumour focus. The
lobe contained one grossly visible tumour
mass 1-2 mm in diameter that was non-
invasive on histological examination (Fig.
6). Histological preparations revealed no
additional microscopic tumour foci.
Analysis of the oestradiol content of
tissues exhibiting various patterns of
tumour growth suggests a relationship
between invasive properties and non-
metabolizedhormonelevelsinthetumour's
microenvironment. Table II shows that
although many organs were capable of
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taking up substantial amounts of labelled
oestradiol from serum, the hormone was
rapidly metabolized to various extents.
During the 60 min in vivo pulse, liver,
brain and periovarian tissues, as well as
s.c. MCF-7 tumour, concentrated labelled
oestradiol. On chromatographic analysis,
however, 7500 of the radiolabel in liver
represented metabolites, whilst only 10%
ofthe label in the uterus was metabolized.
Total radiolabel in lung and subcutaneum
was so low relative to uterus, brain and
tumour, that even without metabolism the
oestradiol content of the tissues was
negligible. Hence we can correlate the
invasive growth patterns in periuterine
tissues and brain with the high levels of
oestradiol achievable in these organs.
Non-invasive growth patterns appear in
microenvironments characterized by low
hormone-concentrating ability.
DISCUSSION
The AICF-7 tumour-cell line produced
tumours at selected visceral sites that
differed markedly in their patterns of
growth. Differences were observed in both
the size of the tumour and its invasion of
the implantation site and adjacent tissues.
Clinically these parameters ofgrowth rate,
site of involvement and degree of invasion
represent the hallmarks distinguishing
resectable, potentially curable disease to
disseminated, aggressive disease of morbid
consequence. These studies reinforce the
FIG. 3.-MCF-7 cells invading peritoneal muscle adjacent to a periuterine tumour (on right)
(H. & E. x 100).
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observation of complex interactions bet- oestrogen to produce tumours in vivo,
ween the tumour and its host tissues to we have studied the effect of this variable
determine which disease type will be on tumour growth patterns at different
manifested. implantation sites. The uterus, perio-
Because the MCF-7 cell line requires varian fat and brain can concentrate
TABLE II.-Concentrations of metabolized and nonmetabolized 17/-oestradiol
Tissue
Periovarian
Uterus
MCF-7 tumour
Whole brain
Liver
Subcutaneum
Lung
Total hormone
concentrated
from serum
(ct/min/mg protein)* % Metabolizedt
10,620 32 + 6
2,169 10+ 5
2,178 30+8
1,071 43+ 3
945 75+ 7
252 ND:
144 ND
Nonmetabolized
17fl-oestradiol
(fmol/mg protein)
80+7
22+1
17+2
7+0 4
3+0 7
ND
ND
* Radiolabel 60 min after injection of3H-17p-oestradiol.
t Mean+s.e. (n=4).
t 3ND =Not done.
-4 4 4
40
FIG. 4.-MCF-7 tumnours invading cerebral tissues following intracerebral injection (H. & E. x 100).
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oestradiolat 10-110-foldgreater concentra-
tions than the lung or s.c. tissues. The
MCF-7 tumour line exhibited aggressive
invasive growth at oestrophilic sites. At
present there are several possible explana-
tions for these observations. The different
growth patterns may result from differ-
ences in local oestradiol concentrations.
Growth ofMCF-7 tumours in the relatively
non-oestrogenic s.c. host tissue requires
the presence of an ectopic hormone supply
(Soule & McGrath, 1980; Russo et al.,
1977, Ozello & Sordat, 1980). In contrast,
MCF-7 tumours in the uterus produce
large invasive tumours in both oestro-
genized anduntreated hosts, which suggest
that local concentrations of oestradiol in
untreated mice are sufficient to support
hormone-dependent tumours, whilst the
microenvironment in the lungs and sub-
cutaneum does not contain sufficient
hormone to support tumours.
Although different growth rates may be
a function of local oestradiol concentra-
tions, changes in growth patterns are not.
These differences in growth patterns may
be the result of differences in oestradiol
bioavailablity. Tumours in lung or s.c.
tissue must depend on their blood supply
for adequate hormone delivery. This may
produce a growth pattern preventing
invasion of the oestradiol-deficient tissues
around the tumour. Tumours in oestrogen-
concentrating tissues, however, may notbe
limited by deficiencies in hormone levels
in the hosttissues and mayrapidly advance
throughout this enriched milieu. Alter-
natively oestradiol may signal the tumour
w_ 11 - +-( -G "' PA-4
s _ b X e~~~~~
FIe.. 5.-Noninvasive s.C. MTICF-7 tumour (H. & E. x 360).
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and/or the host tissue in which it is
implanted to produce a change leading to
invasive growth. A signal to the tumour
might involve the production of soluble
factors (e.g. collagenase) that alter the
structure of susceptible host tissues per-
mitting invasive tumour growth. The
specific host tissue may itself also select
for subpopulations of tumour cells differ-
ing in their ability to invade or respond
to an appropriate stimulus for invasive
growth.
The importance of specific tissue sus-
ceptibility to invasion is further demon-
strated by our observation of differences
in tumour involvement between tissues
adjacent to grossly invasive uterine tum-
ours. Adjacent peritoneal muscle became
involved with invasive tumours (Fig. 3)
but neither kidney nor liver did so. This
finding is in basic agreement with previous
observations that MCF-7 tumours did
not produce hepatic or kidney metastases
(Russo et al., 1977; Soule & McGrath,
1980; Ozzello & Sordat, 1980). However,
there was a single report by Shafie &
Liotta (1980) of a high rate (60%) of
splenic, pleural and hepatic metastases
from s.c. MCF-7 primary tumours. Given
previous reports cited above on the low
metastatic rate for this tumour, and the
general observation that metastatic rates
in adult athymic mice are very low
(Reygarrd, 1973; Sordat et al., 1977;
Wynn-Williams & McCulloch, 1977;
Giovannella et al., 1978) we conclude that
important differences may exist between
Shafie & Liotta's athymic mice or cell
FIG. 6.-Noninvasive pleural MCF-7 tumour arising from intrapleural injection of tumour cells
(H. & E. x 125).
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lines and our own. Despite these differ-
ences, we have observed that sites such as
uterus may permit the development of
highly aggressive tumours with selective
invasion of surrounding tissues. This
indicates that there is an intimate relation-
ship between tumour and host tissue in
generating a combination that permits
violation of the borders of the normal
tissue.
Clearly a great deal of work is needed
to characterize the host-tumour-steroid
relationship. The experiments reported
here serve to document the observation
that local microenvironment of the host
may markedly modulate the rate and
pattern of tumour growth. Further, the
technique of implantation of hormonally
responsive mammary tumours into hor-
monally responsive host tissue may serve
as a model for the study of these inter-
actions. In addition, the use of these
techniques may provide one step in the
attempt to improve the number of
successful primary xenografts from human
mammary tumours.
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